IDEOGEN is a pharmaceutical group specializing in the commercialization of specialty medicines in Europe, focusing on orphan drugs, hepatology, and oncology. The company tailors its operations to therapies for unmet medical needs, offering a range of services from unlicensed through licensed medicines, including market access, quality, and fulfillment requirements for specialized disease segments. The company also engages in research and development, with a focus on identifying novel biomarkers for unmet medical needs related to brain diseases.
Headquarters
Ferko Signature N:175-117 Esentepe Mahallesi Buyukdere Caddesi Sisli
Istanbul; Marmara;
Postal Code: 34394
Contact Details: Purchase the Ideogen Ilac A.S. report to view the information.
Website: http://www.ideogen.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service